Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.01%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 5.34Close
$ 1.13 - $ 5.34 52-Week Range
Ticker Information
Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTAYSHA GENE THERAPIES INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TSHA - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 82K | 1.01% | $ 8.1M |
| 3/31/2025 | $ 92K | 1.27% | $ 7.22M |
| 12/31/2024 | $ 102K | 1.22% | $ 8.33M |
| 9/30/2024 | $ 793K | 8% | $ 9.91M |
| 6/30/2024 | $ 2.24M | 17.4% | $ 12.87M |
| 3/31/2024 | $ 3.65M | 25.81% | $ 14.16M |
| 12/31/2023 | $ 5M | 32.35% | $ 15.45M |
| 9/30/2023 | $ 5.08M | 35.41% | $ 14.35M |
| 6/30/2023 | $ 4.85M | 50.52% | $ 9.6M |
| 3/31/2023 | $ 4.32M | 59.98% | $ 7.21M |
Key Performance Insights, Last 5 Years
- TAYSHA GENE THERAPIES INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, TAYSHA GENE THERAPIES INC's average Int. Exp. % has been 34.98%.
- The median Int. Exp. % for TAYSHA GENE THERAPIES INC during this period was 25.81%
- TAYSHA GENE THERAPIES INC reached its highest Int. Exp. % over the past 5 years at 151.8%.
- The lowest Int. Exp. % recorded by TAYSHA GENE THERAPIES INC in the same timeframe 1.01%
TAYSHA GENE THERAPIES INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for TAYSHA GENE THERAPIES INC is calculated as follows: Int. Exp. [ $ 28K ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ] TSHA - Interest Expense Margin, Last 5 years
1.01%
Minimum
Jun 30, 2025
151.8%
Maximum
Dec 31, 2022
34.98%
Average
25.81%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |